Your browser doesn't support javascript.
loading
Advances in radiotherapy and its impact on second primary cancer risk: A multi-center cohort study in prostate cancer patients.
Jahreiß, Marie-Christina; Hoogeman, Mischa; Aben, Katja Kh; Dirkx, Maarten; Snieders, Renier; Pos, Floris J; Janssen, Tomas; Dekker, Andre; Vanneste, Ben; Minken, Andre; Hoekstra, Carel; Smeenk, Robert J; Incrocci, Luca; Heemsbergen, Wilma D.
Afiliação
  • Jahreiß MC; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Hoogeman M; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Aben KK; Department of Research & Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands; Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Dirkx M; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Snieders R; Department of Research & Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.
  • Pos FJ; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Janssen T; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Dekker A; Department of Radiation Oncology (Maastro), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands.
  • Vanneste B; Department of Radiation Oncology (Maastro), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Human Structure and Repair; Department of Radiation Oncology, Ghent University Hospital, Belgium.
  • Minken A; Radiotherapiegroep, Institute of Radiation Oncology, Arnhem/Deventer, the Netherlands.
  • Hoekstra C; Radiotherapiegroep, Institute of Radiation Oncology, Arnhem/Deventer, the Netherlands.
  • Smeenk RJ; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Incrocci L; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Heemsbergen WD; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands. Electronic address: w.heemsbergen@erasmusmc.nl.
Radiother Oncol ; 183: 109659, 2023 06.
Article em En | MEDLINE | ID: mdl-37003369
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Segunda Neoplasia Primária / Radioterapia Conformacional / Radioterapia de Intensidade Modulada Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Segunda Neoplasia Primária / Radioterapia Conformacional / Radioterapia de Intensidade Modulada Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article